Ausdal Financial Partners, Inc. Bristol Myers Squibb CO Transaction History
Ausdal Financial Partners, Inc.
- $1.1 Billion
- Q4 2024
A detailed history of Ausdal Financial Partners, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 7,334 shares of BMY stock, worth $410,483. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,334
Previous 6,961
5.36%
Holding current value
$410,483
Previous $360,000
15.0%
% of portfolio
0.04%
Previous 0.04%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.54BCall Options Held
32MPut Options Held
34.2M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.37 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.2 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.38 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...